Trials / Unknown
UnknownNCT05599152
Comparison of Myocardial Infarction Patients Who Were Prescribed a Novel Antiplatelet Agent or Clopidogrel
A Study of Clinical Outcomes in Patients With Myocardial Infarction Who Maintained Novel Antiplatelet Agents for 1 Year and Patients Who Switched to Clopidogrel Early
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Chan Joon Kim · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Myocardial infarction is defined according to icd-10 using the data base of South korea National Health Insurance Corporation, where personal identification information has already been removed, and detailed results are derived for each drug category.
Detailed description
The purpose of this study is to compare the prognosis of patients with clopidogrel after early discontinuation of ticagrelor/prasugrel with patients who maintained aspirin and ticagrelor/prasugrel as standard therapy in patients with acute myocardial infarction who underwent percutaneous coronary intervention.
Conditions
Timeline
- Start date
- 2020-05-21
- Primary completion
- 2022-11-01
- Completion
- 2022-11-01
- First posted
- 2022-10-31
- Last updated
- 2022-10-31
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05599152. Inclusion in this directory is not an endorsement.